EDGAR·FLOW

Health Catalyst, Inc. — Form 10-Q

Filed August 6, 2026 · analyzed by the Periodic Agent
10-Q — Neutral significance 2/100
What the filing says
Benjamin Albert (CEO) and Jason Alger (CFO) certified the Q2 2026 10-Q on August 6, 2026, attesting to the accuracy of financial statements, effectiveness of disclosure controls and internal controls over financial reporting, and absence of material misstatements or omissions. No material weaknesses, significant deficiencies, or material fraud were disclosed.
Why this rating

Standard Sarbanes-Oxley Section 302 and 906 certifications are routine quarterly filings with no substantive business changes disclosed.

View original filing on SEC.gov ↗ HCAT · stock on Yahoo Finance ↗

See more from August 6, 2026.

EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.